What is the differential diagnosis and appropriate work‑up for a patient with low white blood cell count, low anion gap, elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST), high vitamin B12, and high high‑density lipoprotein (HDL) cholesterol?

Differential Diagnosis and Work-Up

This constellation of findings—low WBC, low anion gap, elevated transaminases, high B12, and high HDL—most likely represents alcohol-related liver disease (ARLD) with possible nutritional deficiency or hematologic disorder, and requires immediate evaluation with detailed alcohol history, hepatitis serologies, liver imaging, and consideration of bone marrow pathology if B12 is markedly elevated.

Initial Assessment Framework

The pattern you describe requires systematic evaluation based on the hepatocellular injury pattern (elevated ALT/AST) combined with unusual hematologic and metabolic findings.

Hepatocellular Injury Evaluation

For the elevated transaminases, follow the algorithmic approach from the 2018 Gut guidelines 1 and 2023 ACR Appropriateness Criteria 2:

• Determine magnitude of elevation: Mild (<5x upper limit), moderate (5-10x), or severe (>10x upper limit) 2

• Obtain extended liver screen immediately:

  • Hepatitis B surface antigen, hepatitis C antibody
  • Autoimmune markers (ANA, anti-smooth muscle antibody, anti-LKM)
  • Iron studies (ferritin, transferrin saturation)
  • Alpha-1-antitrypsin level
  • Ceruloplasmin (if age >3 years) 1
  • Detailed alcohol consumption history using AUDIT score 1

• Assess for NAFLD risk factors: BMI >25, type 2 diabetes, metabolic syndrome criteria 1

• Perform liver ultrasound as first-line imaging to evaluate for steatosis, cirrhosis, or biliary obstruction 2

Low Anion Gap Significance

A low anion gap (<3 mEq/L by modern ion-selective electrode methodology) is clinically significant 3, 4 and suggests:

• Multiple myeloma or paraproteinemia (most critical to exclude) 3, 4
• Hypoalbuminemia from liver cirrhosis or nephrotic syndrome 4
• Laboratory artifact from hyperlipidemia or severe hyperglobulinemia 4

Order immediately:

• Serum protein electrophoresis (SPEP) with immunofixation
• Albumin level
• Total protein and globulin levels
• Repeat electrolytes to confirm low anion gap 5

Low WBC with High B12

This combination is paradoxical and concerning. Markedly elevated B12 (not supplementation-related) can indicate:

• Hematologic malignancy (leukemia, lymphoma, myeloproliferative disorders) 6
• Liver disease with impaired B12 clearance
• Occult malignancy releasing B12 from tissue stores

However, severe B12 deficiency can also cause pancytopenia 6, though this typically presents with macrocytosis and hypersegmented neutrophils.

Critical next steps:

• Complete blood count with differential and peripheral smear review
• Methylmalonic acid and homocysteine levels (elevated in true B12 deficiency despite high serum B12)
• Intrinsic factor antibodies if deficiency suspected 6
• Consider hematology referral if WBC <3.0 x 10^9/L or abnormal peripheral smear

High HDL Consideration

High HDL is generally protective but can be seen in:

• Chronic alcohol consumption (most relevant here)
• Primary biliary cholangitis
• Genetic lipid disorders

The 2026 ACC/AHA dyslipidemia guidelines 7 do not consider isolated high HDL pathologic, but in this clinical context, it supports alcohol-related etiology.

Integrated Diagnostic Algorithm

Step 1: Urgent exclusions (within 24-48 hours)

• SPEP/immunofixation for multiple myeloma (low anion gap + high B12)
• Hepatitis B/C serologies
• Liver ultrasound
• Peripheral smear review

Step 2: If alcohol history positive (AUDIT >8)

• Calculate FIB-4 or NAFLD Fibrosis Score for risk stratification 1
• If AUDIT >19, refer to alcohol services 1
• If Fibroscan available and >16 kPa, refer to hepatology 1

Step 3: If extended liver screen negative

• Refer to gastroenterology/hepatology per guideline recommendation 1
• Consider liver biopsy if diagnosis remains unclear
• Bone marrow biopsy if hematologic malignancy suspected (persistent cytopenias, abnormal smear, very high B12)

Critical Pitfalls to Avoid

• Do not dismiss low anion gap as laboratory error without excluding paraproteinemia 3—this can be the only clue to multiple myeloma
• Do not assume high B12 is benign—in the absence of supplementation, markedly elevated B12 (>1000 pg/mL) warrants hematologic investigation 6
• Do not use outdated ALT reference ranges—modern URLs are 34 U/L (males) and 22 U/L (females) 8, so "high" ALT may be more significant than traditionally recognized
• Do not delay imaging—ultrasound should be obtained early in the evaluation pathway 1, 2

When to Refer Urgently

Immediate hepatology referral if 1:

• Evidence of synthetic dysfunction (elevated INR, low albumin)
• Clinical signs of cirrhosis or portal hypertension
• Transaminases >10x upper limit
• Fibroscan >16 kPa

Immediate hematology referral if:

• WBC <2.0 x 10^9/L
• Abnormal peripheral smear suggesting malignancy
• B12 >2000 pg/mL without supplementation
• Positive SPEP

The combination of findings suggests a systemic process affecting both liver and bone marrow, making comprehensive evaluation essential before attributing findings to a single benign cause.